Research Activity

The research activities in hematology include both clinical and laboratory research. Details of research interests of each faculty are noted in their individual pages.

Current areas of laboratory research programs include immunobiology of plasma cell diseases, and cellular and molecular biology of blood cell production and hematopoiesis. The research activities are funded by the National Institutes of Health.

Areas of clinical research interest include myeloma and related plasma cell disorders, coagulopathies and non-malignant hematology, sickle cell disease, and palliative care. Other faculty affiliated with the section also carry out basic and clinical research related to hematology. Research programs in hematologic malignancies are in close collaboration with colleagues in the Hematology Program at Yale Cancer Center.

In addition to the individual research programs of primary faculty members of the Section of Medical Oncology and Hematology, collaborative research projects are ongoing with faculty members of several other departments, such as Laboratory Medicine, Pathology, Immunobiology, and Genetics, who have common research interests.

The research activities in medical oncology include both clinical and laboratory research. Details of research interests of each faculty are noted on their individual profile pages. Research programs in medical oncology are in close collaboration with the members of the Yale Cancer Center research programs, particularly the Developmental Therapeutics Research Program.

In addition to the individual research programs led by medical oncology faculty, collaborative research projects are ongoing with faculty members of several other departments, including immunology, genetics, and pharmacology, who have common research interests.

The Translational Research Office facilitates collaboration between the basic scientists across Yale School of Medicine, Yale Cancer Center, and clinicians at Smilow Cancer Hospital, with a goal of bringing promising new therapeutics from the laboratory to patients.